Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Express Scripts
Mallinckrodt
Merck
Queensland Health
Argus Health
Deloitte
Cerilliant

Generated: June 19, 2018

DrugPatentWatch Database Preview

KERLONE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Kerlone patents expire, and what generic alternatives are available?

Kerlone is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in KERLONE is betaxolol hydrochloride. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the betaxolol hydrochloride profile page.
Summary for KERLONE
Drug patent expirations by year for KERLONE
Medical Subject Heading (MeSH) Categories for KERLONE
Synonyms for KERLONE
(.+/-.)-1-[p-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)-2-propanol
(+/-)-1-[p-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)-2-propanol
(+/-)-Betaxolol
(3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2-hydroxypropyl)(propan-2-yl)amine
1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol
1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)propan-2-ol
1-(4-[2-(Cyclopropylmethoxy)ethyl]phenoxy)-3-(isopropylamino)-2-propanol #
1-(isopropylamino)-3-[p-(cyclopropylmethoxyethyl)phenoxy]-2-propanol
1-[(4-{2-[(cyclopropylmethyl)oxy]ethyl}phenyl)oxy]-3-[(1-methylethyl)amino]propan-2-ol
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)-2-propanol
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-{4-[2-(CYCLOPROPYLMETHOXY)ETHYL]PHENOXY}-3-(ISOPROPYLAMINO)PROPAN-2-OL
1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-(propan-2-ylamino)propan-2-ol
2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-
2-Propanol,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-
63659-18-7
63659-19-8 (hydrochloride)
659X187
A834454
AB2000495
AC-1115
AC1L1DIZ
AKOS015841671
ALO-1401-02
AN-1136
API0024704
AS-14125
BC227945
BDBM50405521
beta-Xolol
betaxolol
Betaxolol (Betoptic)
Betaxolol (INN)
Betaxolol (TN)
Betaxolol [INN:BAN]
Betaxolol HCL
Betaxolol S
Betaxololum
Betaxololum [INN-Latin]
Betazolol
Betoptic
Betoptic (TN)
Betoptic S
Betoptic S (TN)
BPBio1_000621
BRD-A02759312-003-03-9
BSPBio_000563
C-19113
C06849
C18H29NO3
CAS-63659-18-7
CC-24642
CCG-204288
CHEBI:3082
CHEMBL423
CS-2452
CTK8F0838
D03ROX
D07526
DB00195
DR001279
DSSTox_CID_2674
DSSTox_GSID_22674
DSSTox_RID_76685
DTXSID2022674
FT-0601531
GTPL549
HMS2089I07
HMS3655P17
HY-B0381
I14-16995
K005
KERLEDEX
Kerlone (TN)
KM0772
KS-00001F72
L000125
Lokren (TN)
Lopac0_000193
LS-122005
MolPort-003-845-027
MRF-0000336
NCGC00015159-04
NCGC00015159-05
NCGC00015159-06
NCGC00015159-08
NCGC00015159-09
NCGC00015159-11
NCGC00024863-03
NCGC00024863-04
NWIUTZDMDHAVTP-UHFFFAOYSA-N
Prestwick0_000382
Prestwick1_000382
Prestwick2_000382
Prestwick3_000382
Q-200713
s2091
SC-23071
SCHEMBL23530
SL 75212
SL-75212
SL-75212-10
SPBio_002484
TC-030604
Tox21_110091
Tox21_110091_1

US Patents and Regulatory Information for KERLONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us KERLONE betaxolol hydrochloride TABLET;ORAL 019507-001 Oct 27, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us KERLONE betaxolol hydrochloride TABLET;ORAL 019507-002 Oct 27, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Healthtrust
Boehringer Ingelheim
Farmers Insurance
Daiichi Sankyo
Cantor Fitzgerald
Accenture
McKesson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.